ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: No Intention Of Retiring, DeVita Says; Bresnick To Head Eppley; Balch Acting Director at Alabama

October 22, 1982

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

Benacerraf Named Farber President

February 8, 1980

Merger Of Centers, Control Programs An Option, Upton Says; ACS To Fund New Prevention Centers

February 2, 1979

Fur New Centers Funded In ’88; More New Consortia On Way

November 25, 1988

Approval Granted For New Formulation of Lupron Depot

July 29, 2011